Robert Maxwell of Privateer Capital takes a close look at recent advancements in cancer treatment, and explains how he’s investing around them. Specifically, he's looking at cryogenic logistics stocks, which play a key role in the cutting-edge treatment process. He also speaks about how to integrate volatile biotech stocks into a balanced portfolio. Filmed December 13, 2017 in Austin, Texas.